Pfizer (NYSE: PFE) reported Q3 EPS of $0.72, $0.01 better than the analyst estimate of $0.71. Revenue for the quarter came in at $12.1 billion versus the consensus estimate of $12.33 billion.

GUIDANCE:

Pfizer sees FY2020 EPS of $2.88-$2.93, versus the consensus of $2.90. Pfizer sees FY2020 revenue of $48.8-49.5 billion, versus the consensus of $49.34 billion.

For earnings history and earnings-related data on Pfizer (PFE) click here.